Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Der Internist|September 6, 2019
[Antibodies in hematology by the example of acute lymphatic leukemia]Gerhard Zugmaier
Journal of Clinical Ultrasound : JCU|January 30, 2004
Color Doppler sonographic signs of respiration-dependent hepatofugal portal flowChristian Görg, Ulf Seifart, Gerhard Zugmaier
Journal of Clinical Ultrasound : JCU|February 21, 2003
The small spleen: sonographic patterns of functional hyposplenia or aspleniaChristian Görg, Miriam Eichkorn, Gerhard Zugmaier
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 11, 2003
Color Doppler sonographic mapping of pulmonary lesions: evidence of dual arterial supply by spectral analysisChristian Görg, Ulf Seifart, Konrad Görg, et al.
Molecular Immunology|April 18, 2015
Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignanciesGerhard Zugmaier, Matthias Klinger, Margit Schmidt, et al.
Annals of Hematology|October 8, 2003
Focal splenic lesions in myeloproliferative disease: association with fatal outcomeChristian Görg, Jordi Riera-Knorrenschild, Konrad Görg, et al.
European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology|November 9, 2002
Bronchioloalveolar carcinoma: sonographic pattern of 'pneumonia'Christian Görg, Ulf Seifart, Ingelore Holzinger, et al.
Pediatric Blood & Cancer|September 14, 2021
CD19 expression in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia pre- and post-treatment with blinatumomabEster Mejstrikova, Matthias Klinger, Ana Markovic, et al.
Immunological Reviews|February 12, 2016
Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directionsMatthias Klinger, Jonathan Benjamin, Roman Kischel, et al.
Pediatric Blood & Cancer|May 29, 2023
Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemiaFranco Locatelli, Ana Markovic, Matthias Klinger, et al.
Pageof 7